Effectiveness of cisplatin monotherapy in standard-risk hepatoblastoma-Reference-Cited by-同舟云学术

Effectiveness of cisplatin monotherapy in standard-risk hepatoblastoma

Published:2022-12-26 Issue:4 Volume:21 Page:31-44
ISSN:2414-9314
Container-title:Pediatric Hematology/Oncology and Immunopathology
language:
Short-container-title:Voprosy gematologii/onkologii i immunopatologii v pediatrii

Author:

Moiseenko R. A.¹^ORCID,Akhaladze D. G.¹^ORCID,Filin A. V.²^ORCID,Kim E. F.³^ORCID,Rabaev G. S.¹^ORCID,Feoktistova E. V.⁴^ORCID,Merkulov N. N.¹^ORCID,Metelin A. V.²^ORCID,Tereshchenko G. V.¹^ORCID,Shchukin V. V.¹^ORCID,Shamanskaya T. V.¹^ORCID,Varfolomeeva S. R.⁵^ORCID,Kachanov D. Y.¹^ORCID

Affiliation:

1. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

2. B.V. Petrovsky National Scientific Center of Surgery

3. Moscow City Oncology Hospital No. 62 of the Department of Health of Moscow

4. Russian Children’s Clinical Hospital of the N.I. Pigorov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation

5. N.N. Blokhin National Medical Research Center of Oncology of Ministry of Healthcare of the Russian Federation

Publisher

Fund Doctors, Innovations, Science for Children

Subject

Oncology,Hematology,Immunology,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Reference29 articles.

1. Lim I.I.P., Bondoc A.J., Geller J.I., Tiao G.M. Hepatoblastoma – The Evolution of Biology, Surgery, and Transplantation. Children (Basel) 2018; 6 (1): 1. DOI:10.3390/children6010001

2. Birch J.M. Epidemiology of Pediatric Liver Tumors. In: Zimmermann A., Perilongo G., Malogolowkin M., von Schweinitz D. (eds.). Pediatric Liver Tumors. Springer; 2011. Rr. 15–23.

3. Czauderna P., Lopez-Terrada D., Hiyama E., Häberle B., Malogolowkin M.H., Meyers R.L. Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 2014; 26 (1): 19–28. DOI:10.1097/MOP.0000000000000046

4. Aronson D.C., Czauderna P., Maibach R., Perilongo G., Morland B. The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials. J Indian Assoc Pediatr Surg 2014; 19 (4): 201–7. DOI:10.4103/0971-9261.142001

5. Perilongo G., Maibach R., Shafford E., Brugieres L., Brock P., Morland B., et al. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med 2009; 361 (17): 1662–70. DOI:10.1056/NEJMoa0810613

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carboplatin/cisplatin/doxorubicin;Reactions Weekly;2023-09-02